Pharmex Industries is a high-growth pharmaceutical company that has aggressively expanded through acquisitions of financially sound firms. The chief financial officer must decide if their latest potential acquisition, the privately owned Formulex Group of Companies, is strategically attractive, and he must also determine the value of the company and how to finance the acquisition.
